SAM
FOMX

Senzar Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Senzar Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-67,429
Closed -$338K – 23
2018
Q2 		$338K Buy
+67,429
New +$347K 0.98% 22
2018
Q1 		– Sell
-377,397
Closed -$2.27M – 39
2017
Q4 		$2.27M Sell
377,397
-85,900
-19% -$517K 0.58% 28
2017
Q3 		$2.57M Sell
463,297
-105,900
-19% -$547K 0.63% 26
2017
Q2 		$2.64M Sell
569,197
-5,600
-1% -$25K 0.65% 22
2017
Q1 		$2.85M Buy
574,797
+23,800
+4% +$229K 0.72% 26
2016
Q4 		$6.12M Buy
550,997
+27,600
+5% +$260K 1.62% 19
2016
Q3 		$4.85M Sell
523,397
-75,000
-13% -$627K 1.25% 23
2016
Q2 		$3.8M Sell
598,397
-1,000,634
-63% -$6.64M 0.83% 30
2016
Q1 		$10.4M Buy
1,599,031
+101,600
+7% +$655K 2.07% 17
2015
Q4 		$12.1M Buy
1,497,431
+633,023
+73% +$4.73M 1.35% 21
2015
Q3 		$6.34M Buy
864,408
+156,959
+22% +$1.6M 0.92% 24
2015
Q2 		$7.25M Buy
707,449
+138,900
+24% +$1.54M 1.25% 29
2015
Q1 		$5.26M Buy
568,549
+55,900
+11% +$500K 1.28% 22
2014
Q4 		$3.59M Buy
+512,649
New +$2.93M 1.05% 28

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Senzar Asset Management's FOMX Position: Q3 2018 in Review

Senzar Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2018, closing a stake of 67,429 shares — an estimated $338K sold.

Senzar Asset Management first reported a position in FOMX in Q4 2014 and held it in 14 quarters. The position peaked at $12.1M in Q4 2015. 75 funds tracked by Wall St. Rank hold FOMX as of Q3 2018.

  • Senzar Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Senzar Asset Management sold 67,429 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2018, an estimated $338K.
  • Senzar Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2014 and held it in 14 quarters.
  • Senzar Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $12.1M in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.